Locally advanced renal cell carcinoma

Journal of the Canadian Urological Association

Volumn 1, Issue 2 SUPPL, 2007, Pages

  Al Otaibi, Mohammed ^a   Tanguay, Simon ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873620047     PISSN: 19116470     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1999. CA Cancer J Clin 1999;49: 8-31.
2. Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carci-noma. J Urol 2001;166:1611-23.
3. Zisman A, Pantuck AJ, Wieder J, et al. Risk group assessment and clinical outcome algo-rithm to predict the natural history of patients with surgically resected renal cell carci-noma. J Clin Oncol 2002;20:4559-66.
4. Leibovich BC, Blute ML, Cheville JC, et al. Prediction of progression after radical nephrec-tomy for patients with clear cell renal cell carcinoma: a stratification tool for prospec-tive clinical trials. Cancer 2003;97:1663-71.
5. Flanigan RC, Salmon SE, Blumenstein BA, et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 2001;345:1655-9.
6. Mickisch GH, Garin A, van Poppel H, et al. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 2001;358:966-70.
7. Motzer RJ, Mazumdar M, Bacik J, et al. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 1999;17:2530-40.
8. Escudier B, Eisen T, Stadler WM, et al. Sorafenib in advanced clear-cell renal-cell car-cinoma. N Engl J Med 2007;356:125-34.
9. Motzer RJ, Hutson TE, Tomczak P, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 2007;356:115-24.
10. Marshall FF. Renal cell carcinoma: surgical management of regional lymph nodes and inferior vena-caval tumor thrombus. Semin Surg Oncol 1988;4:129-32.
11. Novick AC, Kaye MC., Cosgrove DM, et al. Experience with cardiopulmonary bypass and deep hypothermic circulatory arrest in the management of retroperitoneal tumors with large vena caval thrombi. Ann Surg 1990;212:472-6.
12. Swierzewski DJ, Swierzewski MJ, Libertino JA. Radical nephrectomy in patients with renal cell carcinoma with venous, vena caval, and atrial extension. Am J Surg 1994; 168:205-9.
13. Quek ML, Stein JP, Skinner DG. Surgical approaches to venous tumor thrombus. Semin Urol Oncol 2001;19:88-97.
14. Zisman A, Wieder JA, Pantuck AJ, et al. Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy. J Urol2003; 169:909-16.
15. Blute ML, Leibovich BC, Lohse CM, et al. The Mayo Clinic experience with surgical man-agement, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int 2004;94:33-41.
16. Staehler G, Brkovic D. The role of radical surgery for renal cell carcinoma with exten-sion into the vena cava. J Urol 2000;163:1671-5.
17. Hatcher PA, Anderson EE, Paulson DF, et al. Surgical management and prognosis of renal cell carcinoma invading the vena cava. J Urol 1991;145:20-3.
18. Montie JE, el Ammar R, Pontes JE, et al. Renal cell carcinoma with inferior vena cava tumor thrombi. Surg Gynecol Obstet 1991;173:107-15.
19. Glazer AA, Novick AC. Long-term followup after surgical treatment for renal cell carci-noma extending into the right atrium. J Urol 1996;155:448-50.
20. Naitoh J, Kaplan A, Dorey F, et al. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy. J Urol 1999;162:46-50.
21. Bissada NK, Yakout HH, Babanouri A, et al. Long-term experience with management of renal cell carcinoma involving the inferior vena cava. Urology 2003;61:89-92.
22. Moinzadeh A, Libertino JA. Prognostic significance of tumor thrombus level in patients with renal cell carcinoma and venous tumor thrombus extension. Is all T3b the same? J Urol 2004;171:598-601.
23. Leibovich BC, Cheville JC, Lohse CM, et al. Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved? J Urol 2005;173:716-9.
24. Sweeney P, Wood CG, Pisters LL, et al. Surgical management of renal cell carcinoma associated with complex inferior vena caval thrombi. Urol Oncol 2003;21:327-33.
25. Ficarra V, Artibani W. Staging system of renal cell carcinoma: current issues. Eur Urol 2006;49:223-5.
26. Thompson RH, Cheville JC, Lohse CM, et al. Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy. Cancer 2005;104:53-60.
27. Sosa RE, Muecke EC, Vaughan ED Jr, et al. Renal cell carcinoma extending into the inferior vena cava: the prognostic significance of the level of vena caval involvement. J Urol 1984;132:1097-100.
28. Kim HL, Zisman A, Han KR, et al. Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different? J Urol2004; 171:588-91.
29. Goldfarb DA, Novick AC, Lorig R, et al. Magnetic resonance imaging for assessment of vena caval tumor thrombi: a comparative study with venacavography and comput-erized tomography scanning. J Urol 1990;144:1100-3.
30. Glazer A, Novick AC. Preoperative transesophageal echocardiography for assessment of vena caval tumor thrombi: a comparative study with venacavography and mag-netic resonance imaging. Urology 1997;49:32-4.
31. Kallman DA, King BF, Hattery RR, et al. Renal vein and inferior vena cava tumor thrombus in renal cell carcinoma: CT, US, MRI and venacavography. J Comput Assist Tomogr 1992;16:240-7.
32. Pretorius ES, Wickstrom ML, Siegelman ES. MR imaging of renal neoplasms. Magn Reson Imaging Clin N Am 2000;8:813-36.
33. Sohaib SA, Richards PS, Ind T, et al. MR imaging of carcinoma of the vulva. AJR Am J Roentgenol 2002;178:373-7.
34. Ergen FB, Hussain HK, Caoili EM, et al. MRI for preoperative staging of renal cell car-cinoma using the 1997 TNM classification: comparison with surgical and pathologic staging. AJR Am J Roentgenol 2004;182:217-25.
35. Hallscheidt PJ, Fink C, Haferkamp A, et al. Preoperative staging of renal cell carcino-ma with inferior vena cava thrombus using multidetector CT and MRI: prospective study with histopathological correlation. J Comput Assist Tomogr 2005;29:64-8.
36. Gallucci M, Borzomati D, Flammia G, et al. Liver harvesting surgical technique for the treatment of retro-hepatic caval thrombosis concomitant to renal cell carcinoma: perioperative and long-term results in 15 patients without mortality. Eur Urol 2004; 45:194-202.
37. Ciancio G, Hawke C, Soloway M. The use of liver transplant techniques to aid in the surgical management of urological tumors. J Urol 2000;164:665-72.
38. Burt JD, Bowsher WG, Joyce G, et al. The management of renal cell carcinoma with inferior vena-caval involvement. Aust N Z J Surg 1993;63:25-9.
39. Ciancio G, Soloway M. Renal cell carcinoma invading the hepatic veins. Cancer 2001;92:1836-42.
40. Ciancio G, Soloway M. The use of natural veno-venous bypass during surgical treatment of renal cell carcinoma with inferior vena cava thrombus. Am Surg 2002;68:488-90.
41. Vaidya A, Ciancio G, Soloway M. Surgical techniques for treating a renal neoplasm invading the inferior vena cava. J Urol 2003;169:435-44.
42. Jibiki M, Iwai T, Inoue Y, et al. Surgical strategy for treating renal cell carcinoma with thrombus extending into the inferior vena cava. J Vasc Surg 2004;39:829-35.
43. Vaislic CD, Puel P, Grondin P, et al. Cancer of the kidney invading the vena cava and heart. Results after 11 years of treatment. J Thorac Cardiovasc Surg 1986;91:604-9.
44. Marshall FF, Reitz BA, Diamond DA. A new technique for management of renal cell car-cinoma involving the right atrium: hypothermia and cardiac arrest. J Urol 1984;131: 103-7.
45. Stewart JR, Carey JA, McDougal WS, et al. Cavoatrial tumor thrombectomy using cardiopulmonary bypass without circulatory arrest. Ann Thorac Surg 1991;51:717-21.
46. Shinghal R, Vricella LA, Mitchell RS, et al. Cavoatrial tumor thrombus excision with-out circulatory arrest. Urology 2003;62:138-40.
47. Tasca A, Abatangelo G, Ferrarese P, et al. Experience with an elective vacuum assist-ed cardiopulmonary bypass in the surgical treatment of renal neoplasms extending into the right atrium. J Urol 2003;169:75-8.
48. Sarkar R, Eilber FR, Gelabert HA, et al. Prosthetic replacement of the inferior vena cava for malignancy. J Vasc Surg 1998;28:75-81.
49. Gettman MT, Boelter CW, Cheville JC, et al. Charlson co-morbidity index as a predic-tor of outcome after surgery for renal cell carcinoma with renal vein, vena cava or right atrium extension. J Urol 2003;169:1282-6.
50. Lam JS, Shvarts O, Leppert JT, et al. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prog-nostic nomogram and risk group stratification system. J Urol 2005;174:466-72.
51. Dekernion JB, Ramming KP, Smith RB. The natural history of metastatic renal cell carcinoma: a computer analysis. J Urol 1978;120:148-52.
52. Ficarra V, Iafrate M, Cappellaro L, et al. Proposal for reclassification of the TNM staging system in patients with locally advanced (pT3-4) renal cell carcinoma according to the cancer-related outcome. Eur Urol 2007;51:722-9.
53. Stein M, Kuten A, Halpern J, et al. The value of postoperative irradiation in renal cell cancer. Radiother Oncol 1992;24:41-4.
54. Gez E, Libes M, Bar-Deroma R, et al. Postoperative irradiation in localized renal cell car-cinoma: the Rambam Medical Center experience. Tumori 2002;88:500-2.
55. Kjaer M, Frederiksen PL, Engelholm SA. Postoperative radiotherapy in stage II and III renal adenocarcinoma. A randomized trial by the Copenhagen Renal Cancer Study Group. Int J Radiat Oncol Biol Phys 1987;13:665-72.
56. Pantuck AJ, Zisman A, Dorey F, et al. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection. J Urol 2003;169:2076-83.
57. Mills RD, Fleischmann A, Studer UE. Radical cystectomy with an extended pelvic lym-phadenectomy: rationale and results. Surg Oncol Clin N Am 2007;16:233-45.
58. Stein JP, Skinner DG. The role of lymphadenectomy in high-grade invasive bladder can-cer. Urol Clin North Am 2005;32:187-97.
59. Blom JH, van Poppel H, Marechal JM, et al. Radical nephrectomy with and without lymph node dissection: preliminary results of the EORTC randomized phase III proto-col 30881. EORTC Genitourinary Group. Eur Urol 1999;36:570-5.
60. Blute ML, Leibovich BC, Cheville JC, et al. A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with rad-ical nephrectomy for clear cell renal cell carcinoma. J Urol 2004;172:465-9.
61. Canfield SE, Kamat AM, Sanchez-Ortiz RF, et al. Renal cell carcinoma with nodal metas-tases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome. J Urol 2006;175:864-9.
62. Phillips CK, Taneja SS. The role of lymphadenectomy in the surgical management of renal cell carcinoma. Urol Oncol 2004;22:214-23.
63. Uson AC. Tumor recurrence in the renal fossa and/or the abdominal wall after radi-cal nephrectomy for renal cell carcinoma. Prog Clin Biol Res 1982;100:549-60.
64. Sandock DS, Seftel AD, Resnick MI. A new protocol for the followup of renal cell car-cinoma based on pathological stage. J Urol 1995;154:28-31.
65. Levy DA, Slaton JW, Swanson DA, et al. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol 1998;159:1163-7.
66. Itano NB, Blute ML, Spotts B, et al. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy. J Urol 2000;164:322-5.
67. Schrodter S, Hakenberg OW, Manseck A, et al. Outcome of surgical treatment of iso-lated local recurrence after radical nephrectomy for renal cell carcinoma. J Urol 2002; 167:1630-3.
68. Dimarco DS, Lohse CM, Zincke H, et al. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy. Urology2004;64:462-7.
69. Stephenson AJ, Chetner MP, Rourke K, et al. Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy. J Urol2004; 172:58-62.
70. Phillips E, Messing EM. Role of lymphadenectomy in the treatment of renal cell carci-noma. Urology 1993;41:9-15.
71. Tanguay S, Pisters LL, Lawrence DD, et al. Therapy of locally recurrent renal cell car-cinoma after nephrectomy. J Urol 1996;155:26-9.
72. Wiesner C, Jakse G, Rohde D. Therapy of local recurrence of renal cell carcinoma. Oncol Rep 2002;9:189-92.
73. Gogus C, Baltaci S, Beduk Y, et al. Isolated local recurrence of renal cell carcinoma after radical nephrectomy: experience with 10 cases. Urology 2003;61:926-9.
74. Campbell SC, Novick AC. Management of local recurrence following radical nephrec-tomy or partial nephrectomy. Urol Clin North Am 1994;21:593-9.
75. Gittes RF, Blute RD Jr. Repeat bench surgery on a solitary kidney. J Urol1982;127:530-2.
76. Moll V, Becht E, Ziegler M. Kidney preserving surgery in renal cell tumors: indica-tions, techniques and results in 152 patients. J Urol 1993;150:319-23.
77. Master VA, Gottschalk AR, Kane C, et al. Management of isolated renal fossa recur-rence following radical nephrectomy. J Urol 2005;174:473-7.
78. Sandhu SS, Symes A, A'Hern R, et al. Surgical excision of isolated renal-bed recurrence after radical nephrectomy for renal cell carcinoma. BJU Int 2005;95:522-5.
79. Bruno JJ II, Snyder ME, Motzer RJ, et al. Renal cell carcinoma local recurrences: impact of surgical treatment and concomitant metastasis on survival. BJU Int2006;97:933-8.
80. Esrig D, Ahlering TE, Lieskovsky G, et al. Experience with fossa recurrence of renal cell carcinoma. J Urol 1992;147:1491-4.
81. Rabinovitch RA, Zelefsky MJ, Gaynor JJ, et al. Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy. J Clin Oncol 1994;12:206-12.
82. Finney R. The value of radiotherapy in the treatment of hypernephroma -a clini-cal trial. Br J Urol 1973;45:258-69.
83. Hafez KS, Fergany AF, Novick AC. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM stag-ing. J Urol 1999;162:1930-3.
84. Belldegrun A, Tsui KH, deKernion JB, et al. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging sys-tem. J Clin Oncol 1999;17:2868-75.
85. Patard JJ, Kim HL, Lam JS, et al. Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study. J Clin Oncol 2004;22:3316-22.